AB0933 Survival at 6 and 12 months of ustekinumab in patients with psoriatic arthritis in conditions of clinical practice

Autor:	I. Notario Ferreira, M.C. Ramírez Barberena, L. Pérez Albaladejo, A. García Sánchez, M. Á. Ferrer González, R. Cáliz Cáliz, I. Añón Oñate, M.J. Soto Pino, S. Quirosa Flores, J.M. Andreu Ubero, M. Ramírez de la Torre
Rok vydání:	2018
Předmět:	Clinical Practice Psoriatic arthritis medicine.medical_specialty business.industry Ustekinumab medicine In patient medicine.disease business Dermatology medicine.drug
Zdroj:	Psoriatic arthritis.
DOI:	10.1136/annrheumdis-2018-eular.3900
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ed7e6e7be2320b188a7e96ac38e91483 https://doi.org/10.1136/annrheumdis-2018-eular.3900 Zobrazit plný text záznamu